[Federal Register Volume 72, Number 67 (Monday, April 9, 2007)]
[Notices]
[Page 17581]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-6599]


-----------------------------------------------------------------------

 INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-1110 (Preliminary)]


Sodium Hexametaphosphate (SHMP) From China

Determination

    On the basis of the record \1\ developed in the subject 
investigation, the United States International Trade Commission 
(Commission) determines, pursuant to section 733(a) of the Tariff Act 
of 1930 (19 U.S.C. 1673b(a)) (the Act), that there is a reasonable 
indication that an industry in the United States is materially injured 
by reason of imports from China of sodium hexametaphosphate, provided 
for in subheadings 2835.39.50 and 3823.90.39 of the Harmonized Tariff 
Schedule of the United States, that are alleged to be sold in the 
United States at less than fair value (LTFV).
---------------------------------------------------------------------------

    \1\ The record is defined in Sec.  207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------

Commencement of Final Phase Investigation

    Pursuant to Sec.  207.18 of the Commission's rules, the Commission 
also gives notice of the commencement of the final phase of its 
investigation. The Commission will issue a final phase notice of 
scheduling, which will be published in the Federal Register as provided 
in section 207.21 of the Commission's rules, upon notice from the 
Department of Commerce (Commerce) of an affirmative preliminary 
determination in the investigation under section 733(b) of the Act, or, 
if the preliminary determination is negative, upon notice of an 
affirmative final determination in that investigation under section 
735(a) of the Act. Parties that filed entries of appearance in the 
preliminary phase of the investigation need not enter a separate 
appearance for the final phase of the investigation. Industrial users, 
and, if the merchandise under investigation is sold at the retail 
level, representative consumer organizations have the right to appear 
as parties in Commission antidumping and countervailing duty 
investigations. The Secretary will prepare a public service list 
containing the names and addresses of all persons, or their 
representatives, who are parties to the investigation.

Background

    On February 8, 2007, a petition was filed with the Commission and 
Commerce by ICL Performance Products, LP, St. Louis, MO, and Innophos, 
Inc., Cranbury, NJ, alleging that an industry in the United States is 
materially injured or threatened with material injury by reason of LTFV 
imports of sodium hexametaphosphate from China. Accordingly, effective 
February 8, 2007, the Commission instituted antidumping duty 
investigation No. 731-TA-1110 (Preliminary).
    Notice of the institution of the Commission's investigation and of 
a public conference to be held in connection therewith was given by 
posting copies of the notice in the Office of the Secretary, U.S. 
International Trade Commission, Washington, DC, and by publishing the 
notice in the Federal Register of 72 FR 7458, February 15, 2007. The 
conference was held in Washington, DC, on March 1, 2007, and all 
persons who requested the opportunity were permitted to appear in 
person or by counsel.
    The Commission transmitted its determination in this investigation 
to the Secretary of Commerce on March 26, 2007. The views of the 
Commission are contained in USITC Publication 3912 (April 2007), 
entitled Sodium Hexametaphosphate from China: Investigation No. 731-TA-
1110 (Preliminary).

    Issued: April 3, 2007.

    By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
 [FR Doc. E7-6599 Filed 4-6-07; 8:45 am]
BILLING CODE 7020-02-P